DK3325487T3 - Formulering til bløde, anticholinerge analoger - Google Patents
Formulering til bløde, anticholinerge analoger Download PDFInfo
- Publication number
- DK3325487T3 DK3325487T3 DK16828553.4T DK16828553T DK3325487T3 DK 3325487 T3 DK3325487 T3 DK 3325487T3 DK 16828553 T DK16828553 T DK 16828553T DK 3325487 T3 DK3325487 T3 DK 3325487T3
- Authority
- DK
- Denmark
- Prior art keywords
- anticholinerge
- analogs
- formulation
- soft
- anticholinerge analogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461952505P | 2014-03-13 | 2014-03-13 | |
US14/805,114 US20150320722A1 (en) | 2014-03-13 | 2015-07-21 | Formulation for soft anticholinergic analogs |
PCT/US2016/043380 WO2017015485A1 (en) | 2015-07-21 | 2016-07-21 | Formulation for soft anticholinergic analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3325487T3 true DK3325487T3 (da) | 2021-08-02 |
Family
ID=54068191
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15762178.0T DK3116498T3 (da) | 2014-03-13 | 2015-03-12 | Formulering til bløde anticholinerge analoger |
DK16828553.4T DK3325487T3 (da) | 2014-03-13 | 2016-07-21 | Formulering til bløde, anticholinerge analoger |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15762178.0T DK3116498T3 (da) | 2014-03-13 | 2015-03-12 | Formulering til bløde anticholinerge analoger |
Country Status (20)
Country | Link |
---|---|
US (8) | US20150259283A1 (da) |
EP (1) | EP3116498B1 (da) |
JP (5) | JP6293919B2 (da) |
KR (3) | KR102586868B1 (da) |
CN (3) | CN110917124B (da) |
AU (2) | AU2015229243B2 (da) |
BR (1) | BR112016021011B1 (da) |
CA (1) | CA2941649C (da) |
DK (2) | DK3116498T3 (da) |
ES (1) | ES2710292T3 (da) |
HU (1) | HUE041868T2 (da) |
IL (1) | IL247571B (da) |
MX (1) | MX369129B (da) |
MY (1) | MY183531A (da) |
PH (1) | PH12016501732A1 (da) |
PL (1) | PL3116498T3 (da) |
PT (2) | PT3116498T (da) |
SG (1) | SG11201607480SA (da) |
WO (1) | WO2015138776A1 (da) |
ZA (1) | ZA201607071B (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9180081B2 (en) * | 2005-03-03 | 2015-11-10 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
KR102321169B1 (ko) | 2013-08-08 | 2021-11-02 | 노반, 인크. | 국소 조성물 및 그의 사용 방법 |
US20150259283A1 (en) | 2014-03-13 | 2015-09-17 | Brickell Biotech, Inc. | Formulation for soft anticholinergic analogs |
WO2017015485A1 (en) | 2015-07-21 | 2017-01-26 | Bodor Laboratories, Inc. | Formulation for soft anticholinergic analogs |
US10322082B2 (en) | 2014-07-11 | 2019-06-18 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
TWI767507B (zh) * | 2016-07-21 | 2022-06-11 | 美商波德實驗股份有限公司 | 軟性抗膽鹼類似物之製劑 |
US11381304B2 (en) * | 2017-08-30 | 2022-07-05 | Iridium Satellite Llc | Satellite communications with multiple classes of terrestrial terminal devices |
CN114008023B (zh) * | 2019-05-23 | 2024-02-09 | 科研制药株式会社 | 索吡溴铵的晶型及其制备方法 |
TW202146010A (zh) | 2020-03-03 | 2021-12-16 | 日商科研製藥股份有限公司 | 原發性腋窩多汗症的治療方法及其醫藥 |
KR20220149550A (ko) | 2020-03-03 | 2022-11-08 | 가켄 세이야쿠 가부시키가이샤 | 소피로늄 브로마이드를 포함하는 의약 |
KR102655121B1 (ko) | 2021-09-17 | 2024-04-08 | 한국식품연구원 | 락토바실러스 사케이 k040706 균주 검출용 프라이머 세트 및 이의 용도 |
US11807604B1 (en) * | 2022-02-16 | 2023-11-07 | Miralogx Llc | Pharmaceutical compounds, pharmaceutical compositions, and methods of treating asthma and other disorders |
WO2024026412A1 (en) * | 2022-07-28 | 2024-02-01 | Tff Pharmaceuticals, Inc. | Thin film freezing methods and compositions formulated from dispersed active agents |
KR102611847B1 (ko) * | 2023-03-27 | 2023-12-12 | 주식회사 이플라스크 | 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK149832C (da) * | 1981-07-17 | 1987-05-18 | Riemann Claus | Antiperspirantpraeparat bestaaende af to komponenter |
CA2014633C (en) * | 1989-06-02 | 2000-07-18 | Andrew D. Mccrea | Stable anhydrous compositions for topical delivery of active materials |
US5292530A (en) * | 1991-06-02 | 1994-03-08 | Helene Curtis, Inc. | Stable anhydrous topically-active composition and suspending agent therefor |
US5232689A (en) * | 1990-12-21 | 1993-08-03 | Dow Corning Corporation | Translucent antiperspirant compositions |
US5895644A (en) * | 1997-11-20 | 1999-04-20 | Colgate-Palmolive Company | Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same |
US6433003B1 (en) | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
AU2002340058A1 (en) * | 2001-09-26 | 2003-04-07 | Alison B. Lukacsko | Compositions and methods for inhibiting eccrine perspiration in humans |
US8252316B2 (en) * | 2002-05-03 | 2012-08-28 | Purepharm Inc. | Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating |
US20060088496A1 (en) * | 2004-10-25 | 2006-04-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide |
US7087560B2 (en) * | 2004-10-25 | 2006-08-08 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols |
GB0428416D0 (en) * | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
GB0428418D0 (en) * | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
WO2006069998A2 (de) * | 2004-12-27 | 2006-07-06 | Beiersdorf Ag | Glycopyrrolat in kosmetischen zubereitungen |
US10010494B2 (en) * | 2005-10-19 | 2018-07-03 | Menni Menashe Zinger | Methods for the treatment of hyperhidrosis |
AU2006315657B2 (en) * | 2005-11-10 | 2011-12-01 | Shell Internationale Research Maatschappij B.V. | Soft anticholinergic esters |
US7417147B2 (en) | 2005-11-10 | 2008-08-26 | Bodor Nicholas S | Soft anticholinergic zwitterions |
AU2006201878A1 (en) * | 2006-03-13 | 2007-09-27 | Foamix Ltd | Foamable composition for hyperhidrosis |
JP5371235B2 (ja) * | 2006-12-06 | 2013-12-18 | ロート製薬株式会社 | 皮膚外用剤 |
US10265265B2 (en) * | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
WO2009051818A1 (en) | 2007-10-18 | 2009-04-23 | Stiefel Research Australia Pty Ltd | Topical glycopyrrolate formulations |
US20100137357A1 (en) * | 2008-11-26 | 2010-06-03 | Koleng John J | Compositions and methods for hyperhidrosis |
US20140037713A1 (en) * | 2012-08-03 | 2014-02-06 | Antares Pharma Ipl, Ag | Transdermal compositions for anti-cholinergic agents |
US9220707B2 (en) * | 2013-03-15 | 2015-12-29 | Bodor Laboratories, Inc. | Method of dosing and use of soft anticholinergic esters |
WO2015138700A1 (en) | 2014-03-13 | 2015-09-17 | Bodor Laboratories, Inc. | Use of selected anticholinergic zwitterions |
US20150259283A1 (en) | 2014-03-13 | 2015-09-17 | Brickell Biotech, Inc. | Formulation for soft anticholinergic analogs |
-
2014
- 2014-05-22 US US14/285,488 patent/US20150259283A1/en not_active Abandoned
-
2015
- 2015-03-12 PT PT15762178T patent/PT3116498T/pt unknown
- 2015-03-12 DK DK15762178.0T patent/DK3116498T3/da active
- 2015-03-12 CN CN201911319136.8A patent/CN110917124B/zh active Active
- 2015-03-12 HU HUE15762178A patent/HUE041868T2/hu unknown
- 2015-03-12 KR KR1020227028128A patent/KR102586868B1/ko active IP Right Grant
- 2015-03-12 SG SG11201607480SA patent/SG11201607480SA/en unknown
- 2015-03-12 ES ES15762178T patent/ES2710292T3/es active Active
- 2015-03-12 JP JP2016556899A patent/JP6293919B2/ja active Active
- 2015-03-12 CA CA2941649A patent/CA2941649C/en active Active
- 2015-03-12 BR BR112016021011-5A patent/BR112016021011B1/pt active IP Right Grant
- 2015-03-12 US US15/125,039 patent/US20170020845A1/en not_active Abandoned
- 2015-03-12 MX MX2016011529A patent/MX369129B/es active IP Right Grant
- 2015-03-12 EP EP15762178.0A patent/EP3116498B1/en active Active
- 2015-03-12 PL PL15762178T patent/PL3116498T3/pl unknown
- 2015-03-12 MY MYPI2016703307A patent/MY183531A/en unknown
- 2015-03-12 WO PCT/US2015/020253 patent/WO2015138776A1/en active Application Filing
- 2015-03-12 CN CN201910812881.XA patent/CN110420167B/zh active Active
- 2015-03-12 CN CN201580013622.0A patent/CN106456603B/zh active Active
- 2015-03-12 KR KR1020167028122A patent/KR102433868B1/ko active IP Right Grant
- 2015-03-12 AU AU2015229243A patent/AU2015229243B2/en active Active
- 2015-03-12 KR KR1020237033837A patent/KR20230145522A/ko active Application Filing
- 2015-07-21 US US14/805,114 patent/US20150320722A1/en not_active Abandoned
-
2016
- 2016-07-21 DK DK16828553.4T patent/DK3325487T3/da active
- 2016-07-21 PT PT168285534T patent/PT3325487T/pt unknown
- 2016-08-31 IL IL247571A patent/IL247571B/en active IP Right Grant
- 2016-09-02 PH PH12016501732A patent/PH12016501732A1/en unknown
- 2016-10-13 ZA ZA2016/07071A patent/ZA201607071B/en unknown
-
2017
- 2017-09-14 JP JP2017176799A patent/JP6461267B2/ja active Active
-
2018
- 2018-03-28 JP JP2018062716A patent/JP6756763B2/ja active Active
-
2019
- 2019-07-09 JP JP2019127508A patent/JP6762047B2/ja active Active
- 2019-10-30 AU AU2019257421A patent/AU2019257421B2/en active Active
- 2019-11-14 US US16/683,792 patent/US10961191B2/en active Active
- 2019-11-26 US US16/696,077 patent/US10947192B2/en active Active
-
2020
- 2020-03-02 JP JP2020035073A patent/JP2020079321A/ja active Pending
- 2020-11-16 US US17/099,163 patent/US11034652B2/en active Active
- 2020-12-09 US US17/116,501 patent/US11084788B2/en active Active
-
2021
- 2021-03-15 US US17/202,063 patent/US20210198195A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3325487T3 (da) | Formulering til bløde, anticholinerge analoger | |
DK3461821T3 (da) | Indolcarboxamidforbindelser, der er brugbar som kinasehæmmere | |
DK3356313T3 (da) | 2-perfluorhexyloktan til oftalmisk indgivelse | |
DK3072835T3 (da) | Fremgangsmåde til fremføring | |
DK3218504T3 (da) | Trisegmenterede arenavira som vaccinevektorer | |
BR112016023628A2 (pt) | composições farmacêuticas. | |
DK3215173T3 (da) | Glycopeptidsammensætninger | |
DK3298027T3 (da) | Anthelmintiske depsipeptidforbindelser | |
DK3194411T3 (da) | Nukleotidanaloger | |
DK3040326T3 (da) | Haloolefin-baseret sammensætning | |
DK3125898T3 (da) | Farmakofor til trail-induktion | |
FR3024363B1 (fr) | Composition thermogelifiable | |
DK3153508T3 (da) | Naphthofuranderivater til anvendelse som anticancermidler | |
DK3197890T3 (da) | Disubstituerede diaryloxybenzoheterodiazolforbindelser | |
DK3265394T3 (da) | Fremgangsmåde til emballering | |
DK3129007T3 (da) | Vaccinesammensætninger | |
DK3277690T3 (da) | Spirocykliske forbindelser | |
DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
CL2017000639A1 (es) | Composición | |
DK3230929T3 (da) | Forbedringer til tælleranordninger | |
DK3200827T3 (da) | Sammensætninger | |
BR112016017925A2 (pt) | Formulação de colagem estabilizada | |
DK3217964T3 (da) | Sammensætning | |
DK3148513T3 (da) | Ceritinib-formulering | |
FR3019552B1 (fr) | Composition filmogene |